Table 1 Included adult studies
Author | Total patients | Population | Heart disease | Renal failure | SBT type | SBT failure status | BNP type | BNP measure | Dichotomization threshold |
|---|---|---|---|---|---|---|---|---|---|
Cheng L (2015) (Additional file 3) | 56 | Mixed population | Excluded | Excluded | PS/PEEP | Exclude SBT failure | BNP | ΔBNP, ΔBNP% | 80 ng/L, 13.4% |
Chien et al. [4] | 52 | Mixed population | Included | Included | T-tube | Exclude SBT failure | BNP | ΔBNP% | 20% |
Fang M (2010) (Additional file 3) | 126 | Septic shock | Included | Unclear | PEEP | Include SBT failure | NT-proBNP log NT-proBNP | Pre-SBT BNP | 3914.5 ng/L |
Fang M (2013) (Additional file 3) | 52 | Septic shock | Included | Unclear | PEEP | Include SBT failure | NT-proBNP log NT-proBNP | Pre-SBT BNP | N/A |
Farghaly S (2015) (Additional file 3) | 30 | Chronic respiratory failure | Excluded | Excluded | PS/PEEP | Include SBT failure | BNP | Post-SBT BNP ΔBNP% | 164 ng/L, 14.9% |
Haji K (2018) (Additional file 3) | 53 | Mixed population | Included | Included | PEEP | Include SBT failure | BNP | BNP-post | N/A |
Hersh D (2004) (Additional file 3) | 23 | Mixed population | Unclear | Unclear | Unclear | Exclude SBT failure | BNP | Pre-SBT BNP | N/A |
Konomi I (2016) (Additional file 3) | 42 | Mixed population | Included (except valvulopathy) | Included | T-piece | Include SBT failure | BNP | Pre-SBT BNP | N/A |
Lara TM (2013) (Additional file 3) | 101 | Elective CABG with CPB | Included | Excluded (CKD) | Unclear | Include SBT failure | BNP | Post-SBT BNP | 299 ng/L |
Luo L (2017) (Additional file 3) | 60 | Mixed population (failed extubation once) | Included (except MV disease) | Included | T-tube | Exclude SBT failure | NT-proBNP | Post-SBT BNP | N/A |
Ma G (2013) (Additional file 3) | 29 | Cancer patients with pulmonary complications undergoing noncardiac major surgery | Excluded | Excluded | T-tube | Include SBT failure | NT-proBNP | Post-SBT BNP | 448 ng/L |
Maraghi SE (2014) (Additional file 3) | 40 | Mixed population | Excluded | Excluded | T-tube | Exclude SBT failure | BNP | ΔBNP% | 20% |
Martini A (2011) (Additional file 3) | 98 | Unclear | Included | Unclear | Unclear | Unclear | NT-proBNP | ΔBNP | N/A |
Mekontso Dessap et al. [5] | 102 | Mixed population | Included | Excluded | T-Piece PS/PEEP | Include SBT failure | BNP | Pre-SBT BNP, ΔBNP | N/A |
Ouanes-Besbes L (2012) (Additional file 3) | 143 | Mixed population | Included | Excluded (any) | T-tube | Exclude SBT failure | NT-proBNP | Pre-SBT BNP | Rule-in, 2000 ng/L; rule-out, 1000 ng/L |
Soummer A (2012) (Additional file 3) | 100 | Mixed population | Included | Included | T-tube | Exclude SBT failure | BNP | Post-SBT BNP | 267 ng/L |
Wang YT (2016) (Additional file 3) | 82 | Mixed population | Excluded | Excluded | PEEP | Exclude SBT failure | NT-proBNP | Post-SBT BNP | N/A |
Zapata et al. [11] | 100 | Mixed population | Included | Included | T-tube | Exclude SBT failure | BNP NT-proBNP | Pre-SBT BNP, ΔBNP | BNP, 263 ng/L; NT-ProBNP, 1343 ng/L; ΔBNP, 48 ng/L; ΔNT-ProBNP, − 21 ng/L |